, for their ability to modulate engulfment by LR73 fibroblasts, a nonprofessional phagocytic cell line. Of the eleven factors tested, only insulin-like growth factor 1 (IGF-1) significantly dampened apoptotic cell uptake, at concentrations reported in mouse and human serum (100-600 ng ml -1 ) 12 ( Fig. 1a, b) . Other factors such as EGF, FGF2, VEGF, PDGF-AA and PDGF-BB did not alter phagocytic activity over a range of concentrations (Extended Data Fig. 1a ), although each elicited early downstream signalling events (Extended Data Fig. 1b-e) . The engulfment-dampening effect of IGF-1 was also seen with airway epithelial cell lines BEAS-2B and 16HBE14o-, and the endothelial cell line SVEC-40 (Fig. 1c, Extended Data Fig. 1f, g ).
The IGF-1 effect was not due to masking phosphatidylserine (PtdSer) on the apoptotic cells (Fig. 1d ). LR73 cells express the IGF-1 receptor (IGF-1R), and IGF-1 treatment elicited phosphorylation of Akt, a signalling molecule downstream of IGF-1R (Fig. 1b) .
In blood, IGF-1 is bound to IGF-binding proteins (IGFBPs) that stabilize and sequester IGF-1 (ref. 13) . Addition of IGFBP3 with IGF-1 restored the phagocytic capability of LR73 cells (Fig. 1e) , suggesting that binding of active IGF-1 to IGF-1R was necessary. A neutralizing antibody against the human IGF-1R reversed the engulfment-dampening effect of IGF-1 on BEAS-2B cells (Fig. 1f) . Further, OSI-906 (a small molecule kinase inhibitor of IGF-1R currently tested in clinical trials) and the inhibitor NVP-AEW541 rescued the engulfment capacity of LR73 cells treated with IGF-1, with concomitant decrease in phosphorylation of IGF-1R and Erk (Fig. 1g, Extended Data Fig. 2a ). IGF-II and insulin, which share structural similarity with IGF-1 but have lower affinities for IGF-1R 13 , could also reduce apoptotic cell uptake (Extended Data Fig. 2b , c), albeit at higher concentrations. Thus, productive signalling through the IGF-1R is necessary for IGF-1 to dampen apoptotic cell uptake.
In contrast to the inhibitory effect on apoptotic cell uptake, IGF-1 enhanced the uptake of PtdSer-containing liposomes of 150-200 nm in size (Fig. 1h ). This was not seen with EGF or VEGF. IGF-1 enhancement required IGF-1R signalling, as the inhibitor OSI-906 reduced the increased liposome uptake (Fig. 1i) . Thus, IGF-1 can redirect phagocytosis by non-professional phagocytes, suppressing uptake of larger apoptotic cells and enhancing internalization of smaller particles.
The IGF-1 effect was reversible, as washing phagocytes that were pretreated with IGF-1 resulted in near-complete restoration of phagocytic activity (Fig. 1j) . The effect of IGF-1 on phagocytes was also rapid, as adding IGF-1 simultaneously with apoptotic cells inhibited engulfment in a similar manner as that seen with the pre-treated cells (data not shown), which suggests IGF-1 interferes with early step(s) during phagocytosis. Blocking certain early signalling pathways downstream of IGF-1R, such as Akt, mTOR, Erk or PI3-kinase 14 , did not rescue the IGF-1-mediated decrease in apoptotic cell uptake (Extended Data Fig. 3a-d ). Although IGF-1 can activate RhoA, which is known to decrease apoptotic cell engulfment 15 , inhibition of RhoA-mediated signalling did not reverse the suppression of IGF-1-mediated engulfment (Extended Data Fig. 3e , f). Overexpressing activated Rac1 (which promotes apoptotic cell engulfment 16, 17 ) bypassed attenuation of apoptotic cell uptake (Fig. 1k) , suggesting that IGF-1R acts at or before a step regulated by active Rac1. As apoptotic cell uptake requires both Rac1-dependent actin polymerization and de-polymerization 18 , we explored actin regulation via IGF-1. Cytochalasin D (cytoD), which promotes actin depolymerization, potently inhibited phagocytosis of apoptotic cells 3 (data not shown). Although cytoD did not affect the basal uptake of liposomes by LR73 cells, it blocked the IGF-1-induced increase in liposome uptake (Fig. 1l) . Notably, cytoD-treated LR73 cells appeared morphologically normal for the duration of the assay. Latrunculin A, which promotes actin depolymerization through a different mechanism, also reversed IGF-1-mediated enhancement of liposome uptake, without affecting the basal uptake of liposomes (Fig. 1m) . Additionally, Arp2/3 complex can regulate phagocytosis through the formation of branched actin networks; however, CK-666, a small molecule inhibitor of Arp2/3, had minimal effect on the IGF-1-mediated increase of liposome uptake (Extended Data Fig. 3g ).
Collectively, IGF-1-mediated modulation of phagocytosis involves rapid and reversible modification of F-actin/G-actin dynamics, but probably not Arp2/3-mediated functions.
We next tested the effect of IGF-1 on professional phagocytes. Adding IGF-1 to the macrophage cell lines J774 or IC-21, or primary macrophages (bone-marrow-derived or resident peritoneal macrophages), did not affect apoptotic cell uptake, even with supra-physiological concentrations of IGF-1, at every time point analysed (Fig. 1n-p , Extended Data Fig. 4a, d ). Peritoneal macrophages exposed to IGF-1 also had comparable liposome uptake as control-treated cells (Fig. 1q) . Importantly, IGF-1R expression was confirmed in all macrophage cell types analysed (Extended Data Fig. 4c ) and IGF-1 initiated early signalling in macrophages, as assessed by IGF-1R and Akt phosphorylation (Fig. 1n, Extended Data Fig. 4a ). These data suggest that IGF-1-mediated modulation of phagocytosis does not extend to macrophages.
High levels of serum IGF-1 is linked to IGF-1 production in the liver, but macrophages can also produce IGF-1 in response to the cytokine IL-4 (ref. 19) , raising the possibility that within a tissue, IGF-1 release from macrophages could regulate nearby non-professional phagocytes. We first confirmed IGF-1 secretion by peritoneal macrophages treated with IL-4 (Fig. 2a) . Furthermore, resident peritoneal macrophages exposed to apoptotic Jurkat cells (but not live cells) produced IGF-1 (Fig. 2a) . IGF-1 protein induction appears to be from newly transcribed Igf1 mRNA (Extended Data Fig. 5a ). Macrophage-produced IGF-1 could also suppress apoptotic cell uptake by LR73 cells, and this was reversed by addition of IGFBP3 (Fig. 2b) .
We chose to examine lung tissue to investigate in vivo communication between phagocytes, as alveolar macrophages and airway epithelial cells reside in close proximity, and both engulf apoptotic cells 3 . Alveolar macrophages, similar to resident peritoneal macrophages, are derived from fetal monocytes 20 , and are readily isolated through CD11c + Siglec F + expression, whereas the airway epithelial cells can be isolated and tracked with available genetic tools 3 . IGF-1R expression was prominent in the airway epithelial cells (Extended Data Fig. 5b, c) , but was also detectable at lower levels in alveolar macrophages. To test the effect of IGF-1 in vivo, we used mice in which airway epithelial cells are specifically marked by yellow fluorescence protein (YFP). When apoptotic cells or liposomes were administered intranasally with IGF-1 (Fig. 2c) , YFP + airway epithelial cells had decreased apoptotic cell engulfment, but enhanced liposome uptake (Fig. 2d, e) . Importantly, lung macrophages from the same IGF-1-treated mice were unaffected in their ability to engulf these targets (Fig. 2d, e) . Thus, IGF-1 can differentially affect engulfment by professional and non-professional phagocytes that reside nearby in the same tissue. 
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We next examined IGF-1 release by alveolar macrophages in vivo. Intranasal administration of IL-4 or apoptotic Jurkat cells resulted in an increased level of IGF-1 in the bronchoalveolar lavage (BAL) fluid (Fig. 2f) . When we tested IL-13 or IL-5 (cytokines linked to lung homeostasis and inflammation 21 ), IL-13 (whose receptor shares a common subunit with the IL-4R), but not IL-5, induced IGF-1 production (Fig. 2f) . As the source of IGF-1 is difficult to distinguish in these experiments, we generated LysM-Cre/Igf1 fl/fl mice, which express Cre under the control of the endogenous LysM (also known as Lyz2) promoter, and target IGF-1 deletion in the myeloid lineage. LysMCre/Igf1
fl/fl mice showed loss of Igf1 mRNA in alveolar macrophages (Extended Data Fig. 5d ) and IGF-1 induction after treatment with IL-4, IL-13 or apoptotic cells (Fig. 2g ). This suggested that the macrophage/ myeloid population is the predominant source of inducible IGF-1 in the lung.
To investigate IGF-1-IGF-1R signalling in inflammation, we used a model of airway inflammation induced by the allergen house dust mite (HDM) 21 , where apoptotic cell recognition by airway epithelial cells influences inflammation 3 . We administered HDM intranasally in the allergen sensitization and challenge stage, modelling the natural route of allergen encounter (Fig. 3a ). When we first tested LysM-Cre/Igf1 fl/fl mice, these mice proved unsuitable, as we continued to detect variable levels of IGF-1 in the BAL fluid after HDM administration (probably owing to leakage of serum IGF-1 during inflammation). Therefore, we targeted instead IGF-1R on the epithelial cells. We crossed Igf1r fl/fl mice with CCSP-rtTA/tetO-Cre transgenic mice (see Methods), the latter driving Cre under the Club cell secretory protein (CCSP; also known as Scgb1a1) promoter in the epithelial cells of the trachea, bronchi and bronchioles. This CCSP-rtTA/tetO-Cre strain allows for inducible Cre expression through doxycycline administration through drinking water, thereby allowing normal development and gene deletion just before allergen exposure. We observed near-complete loss of IGF-1R on epithelial cells of CCSP-Cre/Igf1r
fl/fl mice after doxycycline treatment (Fig. 3b) . After sensitization and challenge with low-endotoxin HDM, . After 24 h, half of the supernatant was assessed for IGF-1 secretion by ELISA, (right panel) and the other half was incubated with PBS or IGBP3 and then tested in the phagocytosis assay using LR73 cells (right) (representative of n = 3), mean ± s.d. Note, addition of IGFBP3 increases the basal phagocytosis owing to low basal levels of IGF-1 found in the supernatant of unstimulated J774 cells. c-e, CCSP-Cre mice with YFP + Club cells were pre-treated with 1 μ g IGF-1 intranasally for 1 h and then administered targets with or without IGF-1. Uptake of apoptotic thymocytes (d, n = 6 per group) or liposomes (e, n = 3 per group) by alveolar macrophages and airway epithelial cells were then assessed. f, Wild-type mice were given PBS, IL-4, apoptotic cells, IL-5, or IL-13 intranasally for 2 consecutive days, and the BAL fluid assessed for IGF-1 (n = 2-3 mice per group for cytokines, n = 5, 8 for apoptotic cell instillation). g, LysM-Cre/Igf1 +/+ or Igf1 fl/fl mice were given PBS, IL-4 or IL-13, or apoptotic cells intranasally, and BAL fluid assessed for IGF-1 (n = 6, 6, 4 mice per group for rIL-4; n = 6, 4, 4 for rIL-13; n = 6, 9, 9 mice per group for apoptotic cell instillation). Data are mean ± s.e.m. unless otherwise indicated. NS, not significant. P value of < 0.05 (* ), < 0.01 (* * ), or < 0.001 (***). fl/fl mice given PBS or HDM (n = 3-4 mice per condition). Representative histological scoring of inflammation (f) and PAS staining (h) (n = 6-10 sections and 3 mice per condition). All data are presented as mean ± s.e.m. NS, not significant. P value of < 0.05 (* ), < 0.01 (* * ), or < 0.001 (***).
the CCSP-Cre/Igf1r fl/fl mice had greater airway inflammation based on several parameters. (1) There was marked increase in eosinophils and CD4 + T cells in the BAL fluid (Fig. 3c ) and trending increase in inflammatory cells in the lungs (Extended Data Fig. 6a ). (2) Lung-draining lymph nodes were larger and contained more CD4 + T cells (Fig. 3d) . (3) Lung sections showed increased peribronchial and perivascular cellular infiltration (Fig. 3e, f) and greater mucus accumulation after HDM treatment (Fig. 3g, h ). (4) HDM-treated CCSP-Cre/Igf1r fl/fl mice displayed increased airway reactivity after methacholine challenge, a measure of the bronchial hyper-responsiveness (Extended Data  Fig. 6b ). There were more apoptotic cells in lung sections (cleaved caspase 3 staining) in HDM-treated CCSP-Cre/Igf1r
fl/fl mice, probably owing to greater inflammation (Extended Data Fig. 6c) . These data suggested a requirement for IGF-1R in the airway epithelial cells in minimizing inflammation in this model.
These observations were initially surprising, as we expected the loss of IGF-1R on airway epithelial cells to improve apoptotic cell clearance and thereby attenuate, rather than worsen, inflammation. This prompted us to examine the temporal requirement of IGF-1-IGF-1R signalling in epithelial cells during allergen exposure. To distinguish the requirement for IGF-1-IGF-1R signalling at the sensitization versus challenge phase, we administered doxycycline at different times: deleting IGF-1R expression before allergen sensitization (Fig. 4a) , or after the initial allergen sensitization but before the challenge phase (Extended Data Fig. 7a ). Mice with IGF-1R deletion before allergen sensitization showed a significant increase in inflammatory parameters (Fig. 4b) , whereas deletion of IGF-1R after the sensitization phase had minimal effect on disease severity (Extended Data Fig. 7b, c) .
Airway epithelial cells that encounter allergens can produce cytokines, such as TSLP and CSF-2/GM-CSF (that affect dendritic cell maturation), as well as IL-33 and IL-25 that drive type-2 innate lymphoid cells (ILC2s) to proliferate and produce IL-13 (ref. 21) . Human bronchial epithelial cells from individuals with asthma produce elevated levels of IL-6, IL-8, and CSF-2 (ref. 22) , and TSLP released from airway epithelial cells (mice and human) can exacerbate airway inflammation 23 . When we assessed the cytokine profile in the BAL fluid of CCSP-Cre/Igf1r fl/fl mice sensitized with HDM, levels of TSLP and IL-6 were greater (Fig. 4d, e) . We did not find increased levels of IL-33, as seen with Rac1 deletion in airway epithelial cells 3 , but this may be due to differences in inflammatory pathways regulated by the loss of IGF-1R rather than Rac1. These results suggest that IGF-1R in airway epithelial cells limits inflammatory cytokines during the initial antigen exposure/sensitization phase.
Regarding trigger(s) for IGF-1 release from the alveolar macrophages in the sensitization phase, although IL-4 is often considered a classic T H 2 cytokine from the adaptive immune response fl/fl mice sensitized with HDM (Fig. 4c) . Thus, IL-4 and/or apoptotic cells present during the initial allergen exposure could elicit IGF-1 production from alveolar macrophages. +/+ and CCSP-Cre/Igf1r fl/fl mice primed with PBS or HDM. f, Schematic of generation and isolation of alveolarmacrophage-derived microvesicles. g, h, Representative negative-stain EM (g) or cryo-EM (h) images of microvesicles isolated from mouse alveolar macrophages. Images show spherical membrane-bound structures of a range of sizes (yellow arrows). i, Representative ImageStreamX images of microvesicles isolated from mouse alveolar macrophage cell line and primary mouse alveolar macrophages and stained for alveolar macrophage markers. j, Tunable resistive pulse sensing analysis of microvesicles from alveolar macrophages using qNano, pore size 400 nm, to determine frequency and sizing of microvesicles (representative of n = 3). k, BEAS-2B cells treated with IGF-1 (100 ng ml −1 ) were assessed for uptake of alveolarmacrophage-derived microvesicles (MV) (n = 4). l, BEAS-2B cells were treated with HDM either in the presence or absence of alveolarmacrophage-derived microvesicles (MV) for 3 h and assessed for expression of TSLP, CSF2, IL6, IL8 (n = 4). m, Heat map of 10 most differentially expressed genes from RNA-seq analysis of BEAS-2B cells exposed to HDM with or without alveolar macrophage-derived microvesicles. Data presented as mean ± s.e.m. ND, not detected, NS, not significant. P value of < 0.05 (* ), < 0.01 (* * ), or < 0.001 (***).
Letter reSeArCH Alveolar macrophages are reported to release microvesicles containing anti-inflammatory mediators during smoking-induced lung injury 26 . As IGF-1 enhances liposome uptake by airway epithelial cells, we tested whether microvesicles from alveolar macrophages may affect airway epithelial cell response to HDM. Using differential centrifugation and filtration, we isolated and characterized microvesicles from alveolar macrophages (Fig. 4f) . Negative stain and cryoelectron microscopy revealed membrane-bound spherical structures > 100 nm in diameter (Fig. 4g, h) . Through ImagestreamX analysis, we determined that the particles from an alveolar macrophage cell line or primary mouse alveolar macrophages carried markers of lung macrophage origin, CD11c or Siglec F, with variable Annexin V staining (Fig. 4i) . Tunable resistive pulse sensing analysis of microvesicles revealed a mean particle size of 357 ± 148.5 nm (Fig. 4j) , within the reported 100-1,000 nm range for microvesicles 27 . Further, IL-4 treatment of macrophages increased microvesicles secretion (Extended Data Fig. 8a ). In addition, uptake of these microvesicles by BEAS-2B airway epithelial cells was enhanced by IGF-1 (Fig. 4k) . Notably, adding alveolar macrophage-derived microvesicles to HDM-treated BEAS-2B cells resulted in significantly lower TSLP, CSF2, IL6, and IL8 induction (Fig. 4l) . To further explore this, we performed RNA-seq of BEAS-2B cells treated with HDM ± microvesicles. Whereas HDM treatment increased several known genes associated with asthma in humans [28] [29] [30] , such as FGF2, KLF4, IFIT2, and PTX3, adding microvesicles from alveolar macrophages suppressed transcription of these genes in the epithelial cells (Fig. 4m, Extended Data Fig. 8b ). Thus, microvesicles released from alveolar macrophages acting on airway epithelial cells exposed to allergen could dampen airway inflammation.
The data presented here provide several insights into phagocytosis and tissue inflammation. It has long been known that professional and non-professional phagocytes reside in proximity and can engulf dying cells and debris, yet communication between these phagocytes was not understood. The data presented here identifies a rapid, transient, and reversible regulation, wherein soluble IGF-1 from macrophages influences the type of particle taken up by epithelial cells. This transient effect might allow the macrophages to temporarily 'redirect' the non-professional phagocytes towards other function(s). Such a possible hierarchy in cell clearance could provide temporal and spatial cross-communication within a given tissue 9 . Our data identifies a twopart regulation of epithelial cells by macrophages that affects airway inflammation, that is, the secretion of IGF-1 redirects particle uptake, and the release of microvesicles dampens inflammatory cytokine production by epithelial cells (Extended Data Fig. 9 ). IGF-1 is a growth factor widely linked to growth, cellular proliferation, and ageing. Global IGF-1 deletion in mice results in dwarfism and perinatal lethality, and IGF-1 mutations are linked to human diseases 13 . This work identifies a previously unappreciated biological function for the IGF-1-IGF-1R signalling axis as a modulator of airway hyper-responsiveness to allergens with potential therapeutic relevance.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. . To achieve deletion, mice were given doxycycline (1 mg ml −1 ) in drinking water containing 0.4% sucrose for at least 7 days before beginning of allergen administration, unless otherwise noted. Administering doxycycline, a derivative of tetracycline, binds to reverse tetracycline-controlled transactivator (rtTA), which then allows rtTA to bind the tetracycline response element, resulting in Cre expression. We also crossed Igf1 fl/fl mice 33, 34 to LysM-Cre mice to conditionally delete Igf1 in the myeloid lineage. We have previously reported on the generation of CCSP-Cre/YFP + mice 3 . For all in vivo experiments, except generation of apoptotic thymocytes, mice between the ages of 8 and 12 weeks were used. Mice were allocated to experimental groups on the basis of genotype and age-matching. Female and male mice were used for all experiments, except for in vivo engulfment assays in which only male mice were used. All animal procedures were performed according to the protocols provided by the Institutional Animal Care and Use Committee (IACUC) of the University of Virginia. No statistical tests were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Induction of airway inflammation. Mice were given drinking water containing doxycycline (1 mg ml
) seven days before first HDM administration. Mice were primed intranasally with 10 μ g of low endotoxin house dust mite extraction (Indoor Biotechnologies) on days 0, 2, 4 and then challenged intranasally on days 10, 12, and 14. On day 16, mice were collected and analysed for eosinophilic airway inflammation. Alternatively, mice were given three doses of low endotoxin HDM on days 0, 2, and 4 and analysed on day 6 ('sensitization phase'). For the 'challenge phase' , mice that had not received any doxycycline were given three doses of low endotoxin HDM on days 0, 2 and 4, then given doxycycline (in drinking water) from day 4 until the mice were analysed. These mice were also challenged intranasally with three doses of low endotoxin HDM on days 10, 12, and 14 and analysed on day 16 . Collection of BAL fluid, lymph nodes, and lung. For airway inflammation experiments, 0.8 ml of PBS were delivered intratracheally through a cannula. Recovered BAL fluid was centrifuged and the supernatant was frozen at − 80 °C for subsequent Luminex analysis. Collected cells were stained for surface markers to distinguish macrophages, neutrophils, T cells, and eosinophils. For lung collection, mice were perfused through the right ventricle with PBS and the lungs were carefully excised and placed in type-2 collagenase (Worthington Biochemical Corporation) dissolved in HBSS containing Ca 2+ and Mg 2+ . Lungs were minced and then incubated at 37 °C for one h, with vigorous pipetting every 15 min to separate the tissue. The lung homogenate was then passed through a 70-μ m nylon strainer, spun down and treated with red blood cell lysis buffer (Sigma-Aldrich) for 5 min. The cells were then washed and resuspended in PBS containing 0.1% BSA. Draining lymph nodes were carefully extracted, and a single cell suspension was made by passage through a 70-μ m nylon strainer using the flat end of a syringe. Cells were washed and then resuspended in PBS containing 0.1% BSA. Cell staining and total cell numbers. The collected cells were stained for macrophages, neutrophils, T cells, and eosinophils using the following markers: CD11c (eBioscience, N418), Siglec F (BD Biosciences, E50-2440), Ly6G (eBioscience, 1A8), CD11b (eBioscience, M1/70), F4/80 (eBioscience, BM8), CD3 (eBioscience, 145-2C11), CD4 (eBioscience, RM4-5), CD44 (eBioscience, IM7), CD69 (eBioscience, H1.2F3). Absolute cell numbers were determined using AccuCount Particles (Spherotech). Flow cytometry data was collected on FACS Canto I (Becton Dickinson) and analysed with FlowJo (Treestar, Inc.). Microscopy and histology. For haematoxylin and eosin and periodic-acidSchiff (PAS) staining of lung sections, mice were perfused with PBS and a cannula inserted into the trachea. The lungs were gently inflated with 10% formalin at a constant fluid pressure at 25 cm. The trachea was tied off and the entire heart and lung were removed and placed in 10% formalin. Lungs were paraffin embedded, sectioned and stained by HistoTox Labs (Boulder). Additional lung sections were embedded and sectioned by Research Histology Core at University of Virginia and the immunohistochemical staining for IGF-1R, and cleaved caspase 3 was performed by the University of Virginia Biorepository and Tissue Research Facility. Approximately 6-10 images were taken per mice, with a total of 3-4 mice per group, and blindly scored by two independent scorers for inflammation, PAS staining, and cleaved caspase 3 positive cells. Immunofluorescence staining of lung sections was performed at the University of Virginia Cardiovascular Research Center Histological Services. Airway hypersensitivity. Mice were anaesthetized and given a tracheotomy tube that delivered increasing concentrations of aerosolized methacholine. The tracheotomy tube in turn was connected to the inspiratory and expiratory ports of a volume-cycled ventilator (flexiVent; SCIREQ Scientific). Airway resistance was measured at baseline and after each dose of methacholine 35 .
Macrophage isolation.
To obtain bone-marrow-derived macrophages, femurs were removed from 8-week-old mice and flushed with 5 ml of sterile PBS containing 5% FBS. The cell suspension was centrifuged, treated with red blood cell lysis buffer, washed, and then plated onto sterile Petri dishes in DMEM containing 10% L929 media, 10% FBS and 1% penicillin/streptomycin/glutamine. Media was replenished every 2 to 3 days and differentiated cells were used at day 6 after collection. Resident peritoneal macrophages were obtained by flushing the peritoneal cavity of mice with 10 ml of cold PBS containing 5% FBS. Collected cells were spun down, resuspended in X-VIVO 10 (Lonza) and plated at a concentration of 3 × 10 5 cells per well in a 24-well plate for IGF-1 secretion assays, and 5 × 10 5 per well in a 24-well plate for engulfment assays. Floating cells were washed the next day and remaining peritoneal macrophages were used 2 days after isolation. Alveolar macrophages were isolated by flushing the lungs with 1 ml of cold PBS instilled intratracheally (five flushes). Collected cells were centrifuged, resuspended in F12K media containing 10% FBS and 1% penicillin/streptomycin/glutamine, and seeded at 1 × 10 5 cells per well in a 48-well plate. All floating cells were washed away the next day and remaining cells were used in assays 2 days after isolation. Microvesicle isolation. MH-S, mouse alveolar macrophages, or primary mouse alveolar macrophages were seeded. After adherence, the media was replaced with 0.22-μ m-filtered media to remove any contaminating microvesicles. After an overnight incubation, the supernatant was collected and spun at 5,000g to remove cell debris and apoptotic bodies. The pellet was discarded and the resulting supernatant was filtered through a 0.8 μ m filter and spun again at 17,000g. The pelleted microvesicles were then washed with HBSS and then spun again at 17,000g. For engulfment assays, microvesicles were stained with TAMRA for 20 min and then added to BEAS-2B cells for 90 min. For flow cytometry, purified particles were stained with CD11c, Siglec F, and Annexin V (BD Biosciences, 550475) and processed on ImagestreamX imaging flow cytometer (Amnis). Microvesicle size distribution was characterized using qNano (IZON Science) with a NP400 membrane and at least 500 particles were counted. Microvesicles were prepared for cryo-electron microscopy using standard methods and imaged on an FEI TF20 (ref. In vitro engulfment assay. LR73, SVEC-40, BEAS-2B, and 16HBE14o-cells were seeded in a 24-well plate. Thymocytes were isolated from 4-6-week-old mice and induced to undergo apoptosis with dexamethasone. Thymocytes or prepared microvesicles were then stained with either CypHer5E (GE Healthcare, PA15401) or TAMRA (Invitrogen, C-1171). LR73 and SVEC-40 cells were incubated with apoptotic thymocytes at a 1:10 phagocyte to target ratio, BEAS-2B at a 1:5 phagocyte to target ratio, and 16HBE14o-at a 1:20 phagocyte to target ratio for 2 h. Mouse IGF-1 (Sigma-Aldrich), human IGF-1 (Sigma-Aldrich), human IGF-II (Sigma-Aldrich) were added to the phagocytes at the same time as addition of apoptotic targets. For IGFBP3 studies, IGFBP3 (Sigma-Aldrich) was added to media or supernatant from J774 cells for one h to allow IGFBP3 to bind to any available IGF-1, then the mix is added to phagocytes along with apoptotic targets. For all pharmacological studies, phagocytes were pre-incubated with the compounds listed below for one h before addition of apoptotic targets: cytochalasin D 37 Phagocytes were examined to ensure no gross morphological changes occurred owing to drug treatment. Targets were then washed off three times with PBS, and the cells were dissociated from the plate with trypsin and the engulfment assessed by flow cytometry. In vivo engulfment assay. CCSP-Cre/YFP + mice were administered PBS or 1 μ g of IGF-1 intranasally. One h later, 100 million CypHer5E-labelled apoptotic thymocytes with or without IGF-1 were injected intranasally for 3.5 h. The BAL fluid was collected and the lungs excised, minced, and digested into a single-cell suspension. The cells were then stained with appropriate markers: CD11c and Siglec F for alveolar macrophage markers and EpCam (along with YFP expression) for airway epithelial cells and analysed by flow cytometry to assess apoptotic cell uptake by the airway epithelial cells and the alveolar macrophages. Liposome construction. Liposomes were prepared by dissolving the lipids (phosphatidylserine, dioleoyl phosphatidylcholine, cholesterol and the lipid DiD dye) in chloroform, evaporating chloroform under flow of argon gas in a glass vial, then subjecting the lipid layer to overnight lyophilization to remove traces of organic solvent. Then normal saline was added for hydration, and intense vortexing was performed to prepare multilamellar vesicles (MLV). Liposomes were repeatedly filtered through a 0.2-μ m Nuclepore polycarbonate filter to prepare smaller particles. Particle size was verified by dynamic light scattering using Nicomp 370. Immunoblotting. LR73, J774 or BEAS-2B cells were seeded in a 60-mm dish at a concentration of 5 × 10
5
. Cells were serum-starved for 6 h and then stimulated with 100 ng ml −1 of IGF-1 for various time points. Cells were lysed in RIPA buffer and used in western blots. The blots were probed for phospho-Erk1/2 (Cell Signaling Technology, 4370), phospho-Akt (Cell Signaling Technology, 4060), phospho-IGF-1R (Cell Signaling, 3024), total Erk2 (Santa Cruz Biotechnology, sc-154-G), total Akt (Cell Signaling Technology, 4691), total IGF-1R (Cell Signaling, 9750), and anti-Bactin-HRP (Sigma-Aldrich, A3854) followed by chemiluminescence detection. Quantitative RT-PCR. Total RNA was extracted from cells using Quick-RNA Miniprep Kit (Zymo Research) or RNeasy Mini Kit (Qiagen) and cDNA was synthesized using QuantiTect Reverse Transcription Kit (Qiagen) according to manufacturers' instructions. Quantitative gene expression for mouse Igf1, human TSLP, CSF2, IL6, IL8 or housekeeping human or mouse Hprt was performed using Taqman probes (Applied Biosystems) using StepOnePlus Real Time PCR System (ABI). RNA-seq. BEAS-2B cells were treated with HDM and alveolar macrophagederived microvesicles for 3 h. Total RNA was extracted and an mRNA library was prepared using Illumina TruSeq platform and followed by transcriptome sequencing using an Illumina NextSeq 500 cartridge. Four independent experiments were sequenced. Rv3.2.2 was used for graphical and statistical analysis and the R package DESeq2 was used for differential gene expression analysis of RNA-seq data. RNA-seq analysis was performed by the UVa Bioinformatics Core.
Code availability. R code used for bioinformatics analysis and heat map generation is available upon request. Data availability. RNA-seq data have been deposited in the Gene Expression Omnibus under accession code GSE89049. Statistical analysis. Statistical significance was determined using GraphPad Prism 5 or 6 using unpaired Student's two-tailed t-test, one-sample t-test, oneway ANOVA or two-way ANOVA, according to test requirements. Variance was similar between groups. No inclusion/exclusion criteria were pre-established. Grubbs' Outlier Test was used to determine outliers, which were excluded from final analysis. A P value of < 0.05 (indicated by one asterisk), < 0.01 (indicated by two asterisks), or < 0.001 (indicated by three asterisks) were considered significant. 
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